商务合作
动脉网APP
可切换为仅中文
PHILADELPHIA, May 6, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ('Carisma' or the 'Company'), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in a fireside chat at The Citizens JMP Life Sciences Conference on Monday, May 13th at 12:00 pm ET..
费城,2024年5月6日/PRNewswire/--Carisma Therapeutics Inc.(纳斯达克:CARM)(“Carisma”或“公司”)是一家专注于发现和开发创新免疫疗法的临床阶段生物制药公司,今天宣布,总裁兼首席执行官史蒂文·凯利(Steven Kelly)将于5月13日星期一下午12:00参加公民JMP生命科学会议的炉边聊天。。
An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event.
该活动的音频网络广播将在投资者关系网页的公司投资者活动部分提供,并将在活动结束后的有限时间内存档。
About Carisma
关于Carisma
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response.
Carisma Therapeutics Inc.是一家临床阶段的生物制药公司,专注于利用我们专有的巨噬细胞和单核细胞工程平台开发用于治疗癌症和其他严重疾病的转化性免疫疗法。我们已经创建了一个全面的,分化的专有细胞治疗平台,专注于工程化巨噬细胞和单核细胞,这些细胞在先天性和适应性免疫反应中起着至关重要的作用。
Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com..
Carisma总部位于宾夕法尼亚州费城。有关更多信息,请访问www.carismatx.com。。
Investors:
投资者:
Shveta Dighe
Shveta Dighe
Head of Investor Relations
投资者关系主管
investors@carismatx.com
investors@carismatx.com
Media Contact:
媒体联系人:
Julia Stern
朱莉娅·斯特恩
(763) 350-5223
(763) 350-5223
jstern@realchemistry.com
jstern@realchemistry.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-the-citizens-jmp-life-sciences-conference-302135910.html
查看原始内容以下载多媒体:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-the-citizens-jmp-life-sciences-conference-302135910.html
SOURCE Carisma Therapeutics Inc.
来源Carisma Therapeutics Inc。
Company Codes: NASDAQ-NMS:CARM
公司代码:NASDAQ-NMS:CARM
最近内容 查看更多
Marvel Biosciences宣布私募
1 天前
NervGen制药公司将在美国脊髓损伤协会第51届年度科学会议上展示两张海报
1 天前
Biogen在早期读数后放弃Ionis在ALS、Angelman综合征中的合作资产
1 天前
产业链接查看更多
所属赛道